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Background:  Reversing the progression of subclinical diabetic myocardial dysfunction (DMD) to heart failure is desirable, though treatment 
remains undefined. The efficacy of exercise training to improve functional and structural features of subclinical DMD was examined in this 
randomized controlled trial.
Methods:  Rest and exercise stress echocardiography (including diastolic [Em] and systolic [Sm] tissue velocities by color tissue Doppler [mean 
of 6 LV segments]) were performed in 225 asymptomatic pts with type 2 diabetes undergoing treadmill VO2peak testing. Calibrated integrated 
backscatter (cIB) was calculated from parasternal long axis views. LV functional reserve was assessed by rest-to-peak exercise changes in Em and 
Sm. Patients with subclinical DMD but no ischemia (rest Em >1SD below norm; n=49, 60±10y; 47% men) were randomized to 6 months exercise 
training (EXT, n=24; gym based aerobic/strength training, ≥150min/wk) or control (CON, n=25).
Results:  Baseline data were similar between groups. Pts in the EXT group demonstrated significantly improved VO2peak (~12%) and greater 
reduction of cIB compared with CON (Table; intention to treat analysis). Within-group improvements of resting Em in both EXT and CON groups 
resulted in no significant intervention benefit. Rest Sm and Em and Sm reserve remained unchanged.
Conclusion:  Despite a clinically relevant gain in VO2peak and attenuation of myocardial fibrosis (cIB), there was no relative benefit of EXT for LV 
functional improvements. 
Variable
EXT change
Mean (95% CI)
CON change
Mean (95% CI)
Δ EXT vs. Δ CON
P value
VO2peak (mL/kg/min) 3.1 (1.9 to 4.3)‡ -0.2 (-1.3 to 0.9) <0.001
Resting LV function
Rest Em (cm/s) 1.2 (0.7 to 1.6)‡ 0.8 (0.3 to 1.2)† 0.23
Rest Sm (cm/s) 0.3 (-0.1 to 0.8) 0.3 (-0.1 to 0.7) 0.92
cIB -4 (-7 to -2)‡ -1 (-3 to 1) 0.045
LV functional reserve (peak exercise - rest)
Sm reserve (cm/s) 0.2 (-0.3 to 0.7) 0.3 (-0.2 to 0.7) 0.85
Em reserve (cm/s) -0.2 (-0.9 to 0.5) 0.2 (-0.5 to 0.9) 0.41
†p<0.01, ‡p<0.001 for within-group change.
